Pdl Biopharma (PDLI US)

PDL BioPharma Inc. manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. The Company is focused on intellectual property asset management and acquiring new income generating assets.